The mechanisms that regulate the host immune response induced by human metapneumovirus (hMPV), a newly-recognized member of the Paramyxoviridae family, are largely unknown. Cytokines play an important role in modulating inflammatory responses during viral infections. IL-12p40, a known important mediator in limiting lung inflammation, is induced by hMPV and its production is sustained after the resolution phase of infection suggesting that this cytokine plays a role in the immune response against hMPV. In this work, we demonstrated that in mice deficient in IL-12p40, hMPV infection induced an exacerbated pulmonary inflammatory response and mucus production, altered cytokine response, and decreased lung function. However, hMPV infection in these mice does not have an effect on viral replication. These results identify an important regulatory role of IL-12p40 in hMPV infection.
References
[1]
Kahn JS (2003) Human metapneumovirus, a newly emerging respiratory virus. Pediatr Infect Dis J 22: 923–924.
[2]
Williams JV, Wang CK, Yang CF, Tollefson SJ, House FS, et al. (2006) The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J Infect Dis 193: 387–395.
[3]
van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, et al. (2001) A newly discovered human pneumovirus isolated from young children with respiratory tract disease. NatMed 7: 719–724.
[4]
Kahn JS (2006) Epidemiology of human metapneumovirus. Clin Microbiol Rev 19: 546–557.
[5]
Leung J, Esper F, Weibel C, Kahn JS (2005) Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus. J Clin Microbiol 43: 1213–1219.
[6]
Boivin G, De Serres G, Cote S, Gilca R, Abed Y, et al. (2003) Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 9: 634–640.
[7]
Esper F, Martinello RA, Boucher D, Weibel C, Ferguson D, et al. (2004) A 1-year experience with human metapneumovirus in children aged <5 years. J Infect Dis 189: 1388–1396.
[8]
Esper F, Boucher D, Weibel C, Martinello RA, Kahn JS (2003) Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children. Pediatrics 111: 1407–1410.
[9]
Boivin G, De Serres G, Hamelin ME, Cote S, Argouin M, et al. (2007) An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis 44: 1152–1158.
[10]
Falsey AR, Erdman D, Anderson LJ, Walsh EE (2003) Human metapneumovirus infections in young and elderly adults. J Infect Dis 187: 785–790.
[11]
Honda H, Iwahashi J, Kashiwagi T, Imamura Y, Hamada N, et al. (2006) Outbreak of human metapneumovirus infection in elderly inpatients in Japan. J Am Geriatr Soc 54: 177–180.
[12]
Falsey AR (2008) Human metapneumovirus infection in adults. Pediatr Infect Dis J 27: S80–83.
[13]
Schildgen V, van den Hoogen B, Fouchier R, Tripp RA, Alvarez R, et al. (2011) Human Metapneumovirus: Lessons Learned over the First Decade. Clin Microbiol Rev 24: 734–754.
[14]
Laham FR, Israele V, Casellas JM, Garcia AM, Lac Prugent CM, et al. (2004) Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J Infect Dis 189: 2047–2056.
[15]
Guerrero-Plata A, Casola A, Garofalo RP (2005) Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus. J Virol 79: 14992–14997.
[16]
Trinchieri G, Pflanz S, Kastelein RA (2003) The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19: 641–644.
Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, et al. (1995) Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 154: 5071–5079.
[19]
Muller G, Saloga J, Germann T, Bellinghausen I, Mohamadzadeh M, et al. (1994) Identification and induction of human keratinocyte-derived IL-12. J ClinInvest 94: 1799–1805.
[20]
Mikols CL, Yan L, Norris JY, Russell TD, Khalifah AP, et al. (2006) IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. AmJ RespirCrit Care Med 174: 461–470.
[21]
Walter MJ, Kajiwara N, Karanja P, Castro M, Holtzman MJ (2001) Interleukin 12 p40 production by barrier epithelial cells during airway inflammation. J Exp Med 193: 339–351.
[22]
Kalinski P, Vieira PL, Schuitemaker JH, de Jong EC, Kapsenberg ML (2001) Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97: 3466–3469.
[23]
Gately MK, Carvajal DM, Connaughton SE, Gillessen S, Warrier RR, et al. (1996) Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann N Y Acad Sci 795: 1–12.
[24]
Abdi K (2002) IL-12: the role of p40 versus p75. Scand J Immunol 56: 1–11.
[25]
Khader SA, Partida-Sanchez S, Bell G, Jelley-Gibbs DM, Swain S, et al. (2006) Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med 203: 1805–1815.
[26]
Russell TD, Yan Q, Fan G, Khalifah AP, Bishop DK, et al. (2003) IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1. J Immunol 171: 6866–6874.
[27]
Ha SJ, Lee CH, Lee SB, Kim CM, Jang KL, et al. (1999) A novel function of IL-12p40 as a chemotactic molecule for macrophages. J Immunol 163: 2902–2908.
[28]
Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, et al. (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170: 827–845.
[29]
Onari Y, Yokoyama A, Haruta Y, Nakashima T, Iwamoto H, et al. (2009) IL-12p40 is essential for the down-regulation of airway hyperresponsiveness in a mouse model of bronchial asthma with prolonged antigen exposure. Clin Exp Allergy 39: 290–298.
[30]
Gutierrez JG, Valdez SR, Di Genaro S, Gomez NN (2008) Interleukin-12p40 contributes to protection against lung injury after oral Yersinia enterocolitica infection. Inflamm Res 57: 504–511.
[31]
Wang SZ, Bao YX, Rosenberger CL, Tesfaigzi Y, Stark JM, et al. (2004) IL-12p40 and IL-18 modulate inflammatory and immune responses to respiratory syncytial virus infection. J Immunol 173: 4040–4049.
[32]
Kinjo Y, Kawakami K, Uezu K, Yara S, Miyagi K, et al. (2002) Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40. J Immunol 169: 323–329.
[33]
Guerrero-Plata A, Baron S, Poast JS, Adegboyega PA, Casola A, et al. (2005) Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J Virol 79: 10190–10199.
[34]
Bernacki SH, Nelson AL, Abdullah L, Sheehan JK, Harris A, et al. (1999) Mucin gene expression during differentiation of human airway epithelia in vitro. Muc4 and muc5b are strongly induced. Am J Respir Cell Mol Biol 20: 595–604.
[35]
Reid CJ, Gould S, Harris A (1997) Developmental expression of mucin genes in the human respiratory tract. Am J Respir Cell Mol Biol 17: 592–598.
[36]
Zuhdi Alimam M, Piazza FM, Selby DM, Letwin N, Huang L, et al. (2000) Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am J Respir Cell Mol Biol 22: 253–260.
[37]
Guerrero-Plata A, Kolli D, Hong C, Casola A, Garofalo RP (2009) Subversion of pulmonary dendritic cell function by paramyxovirus infections. Journal of Immunology 182: 3072–3083.
[38]
Ehl S, Bischoff R, Ostler T, Vallbracht S, Schulte-Monting J, et al. (2004) The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur J Immunol 34: 1146–1153.
[39]
Tekkanat KK, Maassab H, Berlin AA, Lincoln PM, Evanoff HL, et al. (2001) Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection. Am J Pathol 159: 631–638.
[40]
Evans CM, Koo JS (2009) Airway mucus: the good, the bad, the sticky. Pharmacol Ther 121: 332–348.
[41]
Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, et al. (2004) Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 189: 1856–1865.
[42]
Hamelin ME, Prince GA, Gomez AM, Kinkead R, Boivin G (2006) Human metapneumovirus infection induces long-term pulmonary inflammation associated with airway obstruction and hyperresponsiveness in mice. J Infect Dis 193: 1634–1642.
[43]
Young HW, Williams OW, Chandra D, Bellinghausen LK, Perez G, et al. (2007) Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5′ elements. Am J Respir Cell Mol Biol 37: 273–290.
[44]
Zhu Y, Ehre C, Abdullah LH, Sheehan JK, Roy M, et al. (2008) Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways. J Physiol 586: 1977–1992.
[45]
Gray T, Coakley R, Hirsh A, Thornton D, Kirkham S, et al. (2004) Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL-1beta in human bronchial epithelia. Am J Physiol Lung Cell Mol Physiol 286: L320–330.
[46]
Shtrichman R, Samuel CE (2001) The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol 4: 251–259.
[47]
Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813: 878–888. pp. 878–888.
[48]
Biondillo DE, Konicek SA, Iwamoto GK (1994) Interferon-gamma regulation of interleukin 6 in monocytic cells. Am J Physiol 267: L564–568.
[49]
Sanceau J, Merlin G, Wietzerbin J (1992) Tumor necrosis factor-alpha and IL-6 up-regulate IFN-gamma receptor gene expression in human monocytic THP-1 cells by transcriptional and post-transcriptional mechanisms. J Immunol 149: 1671–1675.
[50]
Afford SC, Pongracz J, Stockley RA, Crocker J, Burnett D (1992) The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils. J Biol Chem 267: 21612–21616.
[51]
Luster AD, Ravetch JV (1987) Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med 166: 1084–1097.
[52]
Cassatella MA, Guasparri I, Ceska M, Bazzoni F, Rossi F (1993) Interferon-gamma inhibits interleukin-8 production by human polymorphonuclear leucocytes. Immunology 78: 177–184.
[53]
Gusella GL, Musso T, Bosco MC, Espinoza-Delgado I, Matsushima K, et al. (1993) IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes. J Immunol 151: 2725–2732.
[54]
Bosco MC, Gusella GL, Espinoza-Delgado I, Longo DL, Varesio L (1994) Interferon-gamma upregulates interleukin-8 gene expression in human monocytic cells by a posttranscriptional mechanism. Blood 83: 537–542.
[55]
Kolli D, Bataki EL, Spetch L, Guerrero-Plata A, Jewell AM, et al. (2008) T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. JVirol 82: 8560–8569.
[56]
Miyamasu M, Yamaguchi M, Nakajima T, Misaki Y, Morita Y, et al. (1999) Th1-derived cytokine IFN-gamma is a potent inhibitor of eotaxin synthesis in vitro. Int Immunol 11: 1001–1004.
[57]
Biacchesi S, Skiadopoulos MH, Tran KC, Murphy BR, Collins PL, et al. (2004) Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. Virology 321: 247–259.
[58]
Stack AM, Malley R, Saladino RA, Montana JB, MacDonald KL, et al. (2000) Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model. Vaccine 18: 1412–1418.
[59]
Haeberle HA, Kuziel WA, Dieterich HJ, Casola A, Gatalica Z, et al. (2001) Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology. J Virol 75: 878–890.
[60]
Nagarkar DR, Wang Q, Shim J, Zhao Y, Tsai WC, et al. (2009) CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human rhinovirus infection. J Immunol 183: 6698–6707.
